Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells-Reference-Cited by-同舟云学术

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

Published:2024-02-22 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Glöckner Hannah Jorinde¹,Martinenaite Evelina¹²,Landkildehus Lisle Thomas¹,Grauslund Jacob¹,Ahmad Shamaila¹,Met Özcan¹³,Thor Straten Per¹,Hald Andersen Mads¹^ORCID

Affiliation:

1. National Center for Cancer Immune Therapy, CCIT-DK, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

2. IO Biotech, Research and Development Department, Copenhagen, Denmark

3. Department of Health Technology, Technical University of Denmark, Lyngby, Denmark

Funder

National Center for Cancer Immune Therapy, CCIT-DK

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2024.2318053

Reference35 articles.

1. Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism

2. Coordinated regulation of myeloid cells by tumours

3. IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice

4. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

5. Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amber Codon Mutational Scanning and Bioorthogonal PEGylation for Mapping Antibody Binding Sites on Human Arginase-1;2024-08-20

2. Harnessing CD8⁺ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions;Clinical and Translational Medicine;2024-06-27